Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$125K Hold
2,313
0.01% 241
2022
Q1
$133K Hold
2,313
0.01% 259
2021
Q4
$109K Sell
2,313
-2,371
-51% -$108K ﹤0.01% 275
2021
Q3
$197K Sell
4,684
-150
-3% -$6.49K 0.01% 305
2021
Q2
$214K Sell
4,834
-89
-2% -$4.11K 0.01% 305
2021
Q1
$230K Buy
4,923
+139
+3% +$6.15K 0.01% 276
2020
Q4
$185K Sell
4,784
-927
-16% -$33.1K 0.01% 300
2020
Q3
$165K Hold
5,711
0.01% 282
2020
Q2
$153K Sell
5,711
-2,148
-27% -$55.9K 0.01% 278
2020
Q1
$185K Sell
7,859
-1,344
-15% -$37K 0.02% 217
2019
Q4
$272K Sell
9,203
-259
-3% -$6.86K 0.02% 208
2019
Q3
$265K Buy
9,462
+1,131
+14% +$32.7K 0.03% 214
2019
Q2
$246K Buy
+8,331
New +$224K 0.02% 222

Other funds holding CTVA

RBC Europe's CTVA Position: Q2 2022 in Review

RBC Europe held its Corteva (CTVA) position steady in Q2 2022 at 2,313 shares worth $125K. The position accounts for 0.01% of the portfolio, ranked #241.

RBC Europe first reported a position in CTVA in Q2 2019 and has held it in 13 quarters since. The position peaked at $272K in Q4 2019. 1,192 funds tracked by Wall St. Rank hold CTVA as of Q2 2022.

  • RBC Europe held 2,313 shares of Corteva worth $125K as of Q2 2022.
  • RBC Europe left its Corteva share count unchanged in Q2 2022.
  • Corteva made up 0.01% of RBC Europe's portfolio in Q2 2022, its #241 holding.
  • RBC Europe first reported a position in Corteva in Q2 2019 and has held it in 13 quarters since.
  • RBC Europe's Corteva position peaked at $272K in Q4 2019.
  • 1,192 funds tracked by Wall St. Rank held Corteva as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.